Methods of pharmacological treatment of benign prostatic hyperplasia in dogs: An update

被引：0

作者：

Pasikowska, Joanna ^{[1
]}

Nizanski, Wojciech ^{[1
]}

机构：

[1] Uniwersytet Przyrodniczy Wroclawiu, Wydzial Med Weterynaryjnej, Katedra Rozrodu Klin Zwierzat Gospodarskich, PL-50366 Wroclaw, Poland

来源：

MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE | 2015年 / 71卷 / 06期

关键词：

benign prostatic hyperplasia; dogs; GnRH analogues; GnRH antagonists; antiandrogens; OSATERONE ACETATE; SEMEN QUALITY; HORMONE; GROWTH; DESENSITIZATION; HYPERTROPHY; DELMADINONE; REGRESSION; RECEPTOR; VOLUME;

D O I：

暂无

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

Benign prostatic hyperplasia (BPH) is the most common disease of the prostate in dogs. It can be treated by surgical or pharmacological methods. Surgical methods are used in non-breeder males or males with pathological changes in the testis. Pharmacological treatment is an alternative for breeder males and old animals with associated diseases. Substances that can be used for medical treatment are GnRH analogues, GnRH antagonists, estrogens, progestogens, antiandrogens, inhibitors of 5 alpha-reductase, antiestrogens, and VDR agonists. This paper presents short characteristics of pharmacological substances that we have used in BPH treatment.

引用

页码：335 / 340

页数：6